Category: MS Research Study and Reports

MS Trial Alert: Investigators Recruiting Nationwide for Study Comparing AHSCT to Other Therapies in Active Relapsing MS

Researchers are committed to finding solutions for everyone affected by MS. Without participants—like you—in research studies, MS research would come…

Stuart Schlossman

Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)

– FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing…

Stuart Schlossman

Having parents who smoked increases risk of pediatric MS: Study

Limiting children’s exposure to cigarette smoke may reduce chances of onset Written by Marisa Wexler, MS | February 26, 2026 Having parents who…

Stuart Schlossman

How Does Alcohol Affect MS?

By Crystal Hoshaw – Published on January 23, 2026Medically Reviewed by Barbara S. Giesser, MD, FAAN, FANA, Dipl. ABLM Note:…

Stuart Schlossman

ACTRIMS 2026: Blocking C3 protein seen to ease MS severity in older mice

Complement system own to reduce disease severity in older mice Written by Lila Levinson, PhD | February 9, 2026 The complement system —…

Stuart Schlossman

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

February 7, 2026 – Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of…

Stuart Schlossman

Congress Approves Funding for MS Research Program, PBM Reforms and More

February 3, 2026 On February 3, 2026, Congress passed a bipartisan FY2026 funding package that included the following: Department of…

Stuart Schlossman

Study Supported by the National Multiple Sclerosis Society Sheds Light on the Brain’s Ongoing Effort to Create Myelin-Making Cells

January 29, 2026 Researchers from Johns Hopkins Medicine discovered that the brain is continually trying to produce myelin-making cells. Supporting…

Stuart Schlossman

EBV can trick the immune system to attack myelin in at-risk individuals

Study shows how a common virus and genetic risk factors interact to trigger MS Written by Marisa Wexler, MS | January 15, 2026…

Stuart Schlossman

Immune Signal Ratio May Predict Progressive Multiple Sclerosis

January 2, 2026 Summary: A long-term study has identified a potential biomarker that could help detect which patients are progressing toward…

Stuart Schlossman

Categories

Latest Blog Posts